Influence of free and immobilized chitosan on a defined human gut microbial ecosystem.

Antimicrobial polymer Bacterial gut isolates Bacteroidetes Covalent immobilization Defined gut microbial community Food preservatives

Journal

Food research international (Ottawa, Ont.)
ISSN: 1873-7145
Titre abrégé: Food Res Int
Pays: Canada
ID NLM: 9210143

Informations de publication

Date de publication:
11 2022
Historique:
received: 04 04 2022
revised: 27 06 2022
accepted: 26 08 2022
entrez: 4 10 2022
pubmed: 5 10 2022
medline: 6 10 2022
Statut: ppublish

Résumé

In this work, the influence of different forms of presentation of chitosan in the human gut microbiota with a defined bacterial community was evaluated. First, the susceptibility of individual gut bacterial isolates against chitosan was studied within a concentration range between 0.125 and 1 mg/mL. Then, the impact of chitosan (0.25 and 1 mg/mL) on a defined human gut microbial ecosystem was studied by metagenomic and metabonomic analyses. The results showed that chitosan in its free form had a high impact on individual isolates with a minimum inhibitory concentration below 1 mg/mL for most of the strains studied. In comparison, chitosan immobilized in the different carriers displayed a diverse effect on gut microbiota. The most susceptible strains were Agathobacter rectalis strain 16-6-I 1 FAA, Clostridium spiroforme strain 16-6-I 21 FAA and Mediterraneibacter faecis strain 16-6-I 30 FAA. The impact of the different modes of presentation of chitosan was strain-specific and species-specific when compared to results obtained from analysis of other strains within the genera Agathobacter, Clostridium and Mediterraneibacter, and therefore a study using a defined ecosystem was needed to extrapolate the results. Significant decreases in defined community richness and diversity and changes in metabolic profile were observed after exposure to free chitosan. Free chitosan produced significant reductions in the abundance of the genera Lachnoclostridium, Anaerotignum, Blautia, Enterococcus, Eubacterium and Ruthenibacterium together with a slight decrease of the production of SCFAs, among other fermentation by-products. The immobilized chitosan significantly alleviated the impact caused by the antimicrobial polymer and significantly increased the relative abundance of the Bacteroidetes phylum compared to free chitosan. These results suggest the significance of assessing the impact of new ingredients and materials included in food on the human gut microbiota with models that simulate the gastrointestinal environment, such as in vitro bioreactor systems.

Identifiants

pubmed: 36192998
pii: S0963-9969(22)00948-6
doi: 10.1016/j.foodres.2022.111890
pii:
doi:

Substances chimiques

Chitosan 9012-76-4

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

111890

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

María Ruiz-Rico (M)

Departamento de Tecnología de Alimentos, Universitat Politècnica de València, Valencia, Spain. Electronic address: maruiri@etsia.upv.es.

Simone Renwick (S)

Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.

Sarah J Vancuren (SJ)

Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.

Avery V Robinson (AV)

Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.

Connor Gianetto-Hill (C)

Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.

Emma Allen-Vercoe (E)

Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.

José M Barat (JM)

Departamento de Tecnología de Alimentos, Universitat Politècnica de València, Valencia, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH